A Successful Strategy to Maximize Pulmonary Fibrosis (PF) Patient Access, Waiting List (WL) and Post-Lung Transplant (LTx) Survival

Pulmonary fibrosis continues to be presented late and requires a rapid transit to LTx. Use of extended and DCD donor organs facilitate a lower mortality risk than continued waitlist time and enable greater LTx access. Despite challenges, the majority of PF patients can reach LTx with excellent 5-yr survival.